Literature DB >> 7664492

B cells capable of spontaneous IgG secretion in cerebrospinal fluid from patients with multiple sclerosis: dependency on local IL-6 production.

L Perez1, J C Alvarez-Cermeño, C Rodriguez, E Roldán, J A Brieva.   

Abstract

Cerebrospinal fluid (CSF) from multiple sclerosis (MS) patients contains B cells capable of spontaneous IgG secretion in vitro. This study analyses the function and regulation of these cells. CSF cells obtained from nine MS patients actively produced IgG during 2-3 days in culture, and the activity decreased when CSF cells were cultured in serum-free medium. CSF cells from four controls did not secrete detectable IgG in vitro. Further experiments revealed that IL-6 played a role on MS CSF IgG-secreting cells, as can be deduced from the following findings: (i) the addition of exogenous IL-6, but not of other cytokines, to serum-free cultures restored missing CSF cell IgG secretion (ii) the inclusion of anti-IL-6, but not of control, blocking MoAb reduced IgG secretion by CSF cells in fetal calf serum (FCS)-containing cultures; and (iii) CSF cells were capable of active IL-6 production in the presence of FCS. These results suggest that endogenous IL-6 production by MS CSF cells seems to be responsible for inducing CSF IgG-secreting B cells to reach terminal differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664492      PMCID: PMC1553234          DOI: 10.1111/j.1365-2249.1995.tb03133.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

1.  Cerebrospinal fluid lymphocytes from patients with multiple sclerosis do not increase immunoglobulin or measles antibody production after stimulation with pokeweed mitogen.

Authors:  A Henriksson; S Kam-Hansen; P Forsberg; M Grandien
Journal:  J Neuroimmunol       Date:  1986-03       Impact factor: 3.478

2.  Human tonsil, blood and bone marrow in vivo-induced B cells capable of spontaneous and high-rate immunoglobulin secretion in vitro: differences in the requirements for factors and for adherent and bone marrow stromal cells, as well as distinctive adhesion molecule expression.

Authors:  J A Brieva; E Roldán; C Rodríguez; G Navas
Journal:  Eur J Immunol       Date:  1994-02       Impact factor: 5.532

Review 3.  Pathogenesis of multiple sclerosis.

Authors:  C Ffrench-Constant
Journal:  Lancet       Date:  1994-01-29       Impact factor: 79.321

4.  Interleukin 6 is essential for antibody secretion by human in vivo antigen-induced lymphoblastoid B cells.

Authors:  J A Brieva; R A Martin; O Martinez-Maza; J Kagan; J Merrill; A Saxon; J Van Damme; R H Stevens
Journal:  Cell Immunol       Date:  1990-10-15       Impact factor: 4.868

5.  Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis.

Authors:  T Olsson; S Baig; B Höjeberg; H Link
Journal:  Ann Neurol       Date:  1990-02       Impact factor: 10.422

Review 6.  Biological and clinical aspects of interleukin 6.

Authors:  T Hirano; S Akira; T Taga; T Kishimoto
Journal:  Immunol Today       Date:  1990-12

7.  Cytokine network regulating terminal maturation of human bone marrow B cells capable of spontaneous and high rate Ig secretion in vitro.

Authors:  E Roldán; C Rodriguez; G Navas; C Parra; J A Brieva
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

8.  Essential role of tumor necrosis factor-alpha in the differentiation of human tonsil in vivo induced B cells capable of spontaneous and high-rate immunoglobulin secretion.

Authors:  C Rodríguez; E Roldán; G Navas; J A Brieva
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

9.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

  9 in total
  2 in total

1.  Modulation of hypothalamic-pituitary-adrenal function by transgenic expression of interleukin-6 in the CNS of mice.

Authors:  J Raber; R D O'Shea; F E Bloom; I L Campbell
Journal:  J Neurosci       Date:  1997-12-15       Impact factor: 6.167

2.  B cells as a target of immune modulation.

Authors:  Kathleen Hawker
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.